14 Jan 2015 | Infection Prevention & Control
In December 2014 the British High Commission released the first paper from an independent review of antimicrobial resistance, Antimicrobial resistance: Tackling a crisis for the health and wealth of nations.
Early research commissioned by the review suggests that if the world fails to act to control resistance, this toll will exceed $10 million each year by 2050 and have cost the world over $100 trillion USD in lost output. Meanwhile, the pipeline of new drugs in development to replace these is limited, with the rate of discovery of new drugs failing to keep pace with the rise of resistance.
The review will recommend a package of actions that they think should be agreed internationally to tackle this growing threat.
Read the paper Antimicrobial resistance: Tackling a crisis for the health and wealth of nations and find out more about the review at http://amr-review.org/.